# EDGAR Filing Document

**Accession Number:** 0000815094
**File Stem:** 0001193125-23-000286
**Filing Date:** 2023-1
**Character Count:** 2727
**Document Hash:** f34bec86334ef8f8085ab5fcb2da51ff
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-000286.hdr.sgml**: 20230103

**ACCESSION NUMBER**: 0001193125-23-000286

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230103

**DATE AS OF CHANGE**: 20230103

**EFFECTIVENESS DATE**: 20230103

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ABIOMED INC
- **CENTRAL INDEX KEY:** 0000815094
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 042743260
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-09585
- **FILM NUMBER:** 23500291

**BUSINESS ADDRESS:**
- **STREET 1:** 22 CHERRY HILL DR
- **CITY:** DANVERS
- **STATE:** MA
- **ZIP:** 01923
- **BUSINESS PHONE:** 9787775410

**MAIL ADDRESS:**
- **STREET 1:** 22 CHERRY HILL DRIVE
- **CITY:** DANVERS
- **STATE:** MA
- **ZIP:** 01923

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**FORM 15** 

------

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934.** 

**Commission File Number<u> </u>001-09585** 

------

## ABIOMED, Inc.
**(Exact name of registrant as specified in its charter)** 

------

**22 Cherry Hill Drive** 

**Danvers, Massachusetts 01923** 

**(978) 646-1400** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Common Stock, par value $0.01 per share** 

**(Title of each class of securities covered by this Form)** 

**None** 

**(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)** 

------

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
|  Rule 12g-4(a)(1) | ☒ |
|  Rule 12g-4(a)(2) | ☐ |
|  Rule 12h-3(b)(1)(i) | ☒ |
|  Rule 12h-3(b)(1)(ii) | ☐ |
|  Rule 15d-6 | ☐ |
|  Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, ABIOMED, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
|  | ABIOMED, Inc. | ABIOMED, Inc. |
| Date: January 3, 2023 | By: | /s/ Nonna Akopyan |
|  |  | Name: Nonna Akopyan |
|  |  | Title: Secretary |

---

------